The U.S. Securities and Exchange Commission on July 29 accepted CME Group's petition to review its own staff's conditional approval of Nasdaq PHLX's cash-settled Bitcoin index options, ticker QBTC. The approval, originally granted May 22, has been stayed since CME filed its formal challenge on Ju...
"Options that derive their value directly from Bitcoin — a commodity — belong to the CFTC's remit, and a securities exchange cannot sidestep that framework by wrapping the exposure in an index." — CME Group, Petition for Commission Review
The U.S. Securities and Exchange Commission on July 29 accepted CME Group's petition to review its own staff's conditional approval of Nasdaq PHLX's cash-settled Bitcoin index options, ticker QBTC. The approval, originally granted May 22, has been stayed since CME filed its formal challenge on June 11. Public comments are due August 24. No timeline exists for a final ruling.
The dispute is structural, not procedural. CME argues that because Bitcoin is a commodity — a classification the CFTC formalized in its 2015 Coinflip order — any options contract deriving value from Bitcoin's price falls under exclusive CFTC jurisdiction. The SEC's Division of Trading and Markets had approved the product under delegated authority. The full five-member Commission will now decide whether that approval stands, gets modified, or gets vacated.
At stake is more than a single product listing. The outcome will determine whether securities exchanges can list commodity-linked derivatives under SEC rules, potentially opening a parallel regulatory pathway that bypasses CFTC registration. The Bitcoin derivatives market, now carrying approximately $55.76 billion in total options open interest globally, is the immediate arena. The precedent extends to any commodity-based derivative product.
Nasdaq PHLX's proposed QBTC contract is a European-style, cash-settled Bitcoin index option. Key specifications:
The smaller contract size and equity-exchange accessibility were designed to attract retail and smaller institutional participants who lack futures commission merchant (FCM) relationships. The product would have competed directly with CME's existing BTC options, IBIT options on Nasdaq, and Cboe's Bitcoin ETF index options (CBTX/MBTX).
A critical detail: QBTC uses CME-affiliated CF Benchmarks infrastructure for both its underlying index and final settlement price, while competing directly with CME's own derivatives listed under CFTC supervision. Nasdaq had separately pursued CFTC exemptions required before QBTC could trade, a dual-regulator pathway that CME's challenge now calls into question.
The jurisdictional question is not new. Since the CFTC's 2015 Coinflip ruling classified Bitcoin as a commodity, regulatory authority over Bitcoin derivatives has nominally rested with the CFTC. The SEC regulates securities. The divide has generally held, with CME listing Bitcoin futures and options under CFTC oversight since December 2017.
QBTC complicates this boundary. Nasdaq's approach routes the product through SEC approval as an index option listed on a securities exchange, while simultaneously seeking CFTC exemptions for the underlying commodity exposure. CME's petition argues this constitutes regulatory arbitrage — a securities exchange listing a commodity-derived product without registering under the Commodity Exchange Act's framework.
CME's specific claims, as outlined in its petition:
The SEC has not published a substantive response. The July 29 order accepted CME's petition under SEC Rule 431, which automatically stays the underlying approval pending full Commission review.
| Date | Event | |------|-------| | 2015 | CFTC Coinflip order classifies Bitcoin as a commodity | | Dec 2017 | CME launches Bitcoin futures under CFTC | | Nov 2024 | IBIT options launch on Nasdaq, recording 70M call options at $100 strike on day one | | 2024 | Nasdaq and CF Benchmarks begin developing QBTC product | | May 22, 2026 | SEC Division of Trading and Markets grants Nasdaq PHLX conditional approval for QBTC | | May 29, 2026 | CME rolls out 24/7 trading for BTC and ETH futures and options | | June 11, 2026 | CME files formal petition for review; automatic stay takes effect | | July 29, 2026 | Full SEC Commission accepts petition, formalizes stay | | Aug 3, 2026 | Order published in Federal Register | | Aug 24, 2026 | Public comment deadline | | TBD | SEC final ruling |
The dispute lands in a derivatives market that has grown substantially since Bitcoin futures launched in 2017.
Global Bitcoin Options Open Interest: Approximately $55.76 billion across all venues, according to CoinGlass data from mid-2026. Deribit holds $46.24 billion (83%), far ahead of CME at $4.50 billion (8%).
IBIT Options: BlackRock's iShares Bitcoin Trust ETF options reached $27.61 billion in open interest by April 2026, briefly surpassing Deribit's $26.9 billion. IBIT trades under SEC-regulated equity options rules on Nasdaq.
CME Crypto Derivatives: Average daily volume of 407,200 contracts in 2026, up 46% year-over-year. The exchange recorded $3 trillion in notional crypto derivatives volume in 2025. CME launched 24/7 crypto trading on May 29, 2026, clearing approximately $50 million across 7,200 contracts in its debut weekend.
Total Crypto Derivatives Market: Global crypto derivatives trading hit $85.7 trillion in 2025. Derivatives accounted for 73.2% of total crypto market volume by February 2026, per CoinGlass Q1 2026 data. Bitcoin futures open interest stood at approximately $43.78 billion (651,350 BTC).
Existing SEC-Regulated Products: Cboe's CBTX and MBTX Bitcoin ETF index options were approved for Global Trading Hours in April 2026. These track baskets of Bitcoin ETFs rather than a direct Bitcoin price index, a structural distinction from QBTC's direct commodity-price reference.
Bitcoin traded near $64,017 on August 2, recovering to approximately $64,400 after the Federal Reserve held rates at 3.50%–3.75%.
CME's challenge carries a commercial dimension. The exchange has invested heavily in crypto derivatives infrastructure since 2017 and faces increasing competition from SEC-regulated venues.
IBIT options already demonstrate that SEC-regulated platforms can attract substantial Bitcoin derivatives volume. IBIT's $27.61 billion open interest exceeds CME's $4.50 billion in Bitcoin options. The growth trajectory is clear: IBIT launched in November 2024 and overtook Deribit within 18 months.
QBTC would represent a further competitive incursion. Unlike IBIT options — which reference the ETF share price and thus are securities derivatives — QBTC references Bitcoin's commodity price directly. If approved, it would establish that SEC-regulated exchanges can list options on commodity benchmarks, potentially eliminating the regulatory distinction that currently channels commodity derivatives through CFTC-registered venues.
CME warned in its petition that the approval could extend to other commodities. If Nasdaq can list Bitcoin index options under SEC rules, there is no structural barrier to listing gold, crude oil, or natural gas index options on securities exchanges — products that have exclusively traded on CFTC-regulated platforms.
Coinbase's $2.9 billion acquisition of Deribit in August 2025 further consolidated the derivatives landscape. Bernstein analysts project that 3-4 major regulated platforms will control 75% of U.S. crypto derivatives volume by 2027. The QBTC ruling will influence which regulatory framework those platforms operate under.
The SEC Commission has three options under Rule 431:
1. Uphold the approval. QBTC proceeds to listing, pending separate CFTC exemptions. This would validate the SEC's authority to approve commodity-referenced index options on securities exchanges. Precedent: securities exchanges could list similar products on other commodities.
2. Modify the approval. The Commission could impose additional conditions — expanded position limits, enhanced surveillance requirements, or coordination mechanisms with the CFTC. The product would proceed in altered form.
3. Vacate the approval. QBTC is canceled. Nasdaq would need to either register the product under the CFTC framework or redesign it to reference a security (such as a Bitcoin ETF) rather than the commodity price directly.
The third outcome would preserve the existing jurisdictional boundary but would not address the underlying tension. SEC-regulated IBIT options already provide substantial Bitcoin derivatives exposure through the ETF wrapper. The structural question — whether the ETF layer is a meaningful regulatory distinction or a cosmetic one — remains unresolved regardless of the QBTC ruling.
A 2023 memorandum of understanding between the SEC and CFTC aimed to clarify jurisdictional boundaries. The QBTC dispute suggests that MOU has not resolved the core question for derivatives referencing assets classified as commodities.
The QBTC dispute is a jurisdictional test case with implications well beyond Bitcoin. The crypto derivatives market's growth — $85.7 trillion in global volume in 2025, with derivatives accounting for 73% of total crypto trading — has made these products too large for regulatory ambiguity. The SEC and CFTC's overlapping mandates, workable when Bitcoin derivatives were a niche market, now govern tens of billions in open interest.
CME's challenge is commercially motivated but legally substantive. The Commodity Exchange Act's grant of exclusive jurisdiction over commodity options is well-established law. Whether a securities exchange can route around that exclusivity through index-option structuring and dual-agency exemptions is an open question that the 2023 MOU did not answer.
The August 24 comment deadline will produce industry submissions that are likely to split along competitive lines: CME and futures industry participants opposing, securities exchanges and equity-market participants supporting. The Commission's decision, when it arrives, will set the regulatory architecture for the next generation of commodity-linked derivatives — crypto and otherwise.